AKT1 and hepatocellular carcinoma: Furthermore, hsa_circ_0001964 promotes tumor growth in HBV-related HCC by inhibiting the PI3K/AKT signaling cascade and its downstream effector, such as c-Jun, c-Myc, and CCND, which is involved in cell cycle arrest (80).